FdaApplication
NDA 214665
Identifiers
- fda_app_no: NDA214665
Properties
| Property | Value |
|---|---|
| applicant_name | AMGEN INC |
| application_type | NDA |
| approval_date | 2021-05-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUMAKRAS | SOTORASIB | 320MG | TABLET;ORAL |
| LUMAKRAS | SOTORASIB | 240MG | TABLET;ORAL |
| LUMAKRAS | SOTORASIB | 120MG | TABLET;ORAL |
3 products